Skip to main content
FinSpry Logo
FinSpry
EXEL logo
EXEL
(NASDAQ)
Exelixis, Inc.
$43.88-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Exelixis (EXEL) Stock Price & Financial Analysis

Exelixis Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$43.32 - $43.91
52-Week High$49.62
52-Week Low$32.38
Open$43.74
Volume1.66M
Average Volume (3M)1.66M
Market Cap12.37B
Shares Outstanding281.86M
P/E Ratio (TTM)15.86
Forward P/E10.57
Price to Sales (P/S)5.35
Price to Book (P/B)5.74
EV/EBITDA13.13
Revenue (TTM)2.32B
Net Income (TTM)782.57M
Free Cash Flow (TTM)844.34M
EPS (TTM)$2.78
Profit Margin33.73%
Operating Margin38.48%
Return on Equity (ROE)36.21%
Debt to Equity0.08
50-Day MA$42.72
200-Day MA$41.57
52-Week Change21.02%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Exelixis

What is the current stock price for EXEL?

As of the latest trading session, EXEL stock trades at $43.88. The 52-week range is $32.38–$49.62, with a day range of $43.32–$43.91.

What is the P/E ratio for EXEL?

Exelixis's trailing P/E ratio is 15.9, meaning investors pay $15.9 for every $1 of annual earnings. The forward P/E is 10.6, reflecting analyst expectations for future earnings. Exelixis operates in the Healthcare sector.

Does EXEL pay dividends?

Exelixis does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for EXEL?

Based on 6 analysts, the consensus for EXEL is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of EXEL?

Exelixis's market capitalization is $12.37B, classifying it as a large-cap company. Exelixis operates in the Healthcare sector within the Biotechnology industry.